Avinger, Inc. (AVGR) Stock Analysis | Price, Returns, Financials & Key Metrics

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

2.59 M

Shareholding (Sep 2024)

FII

0.00%

Held by 3 FIIs

DII

98.4%

Held by 2 DIIs

Promoter

0.00%

How big is Avinger, Inc.?

22-Jun-2025

As of Feb 14, Avinger, Inc. has a market capitalization of $1.57 million, with net sales of $7.27 million and a net profit of -$18.61 million over the last four quarters. The company's balance sheet shows shareholder's funds of -$6.20 million and total assets of $13.77 million.

What does Avinger, Inc. do?

22-Jun-2025

Avinger, Inc. is a medical device company that develops image-guided, catheter-based systems for treating peripheral arterial disease (PAD). As of September 2024, it reported net sales of $2 million and a net loss of $4 million, with a market cap of $1.57 million.

Should I buy, sell or hold Avinger, Inc.?

22-Jun-2025

Who are in the management team of Avinger, Inc.?

22-Jun-2025

As of March 2022, Avinger, Inc.'s management team includes Mr. James Cullen as Non-Executive Independent Chairman, Mr. Jeffrey Soinski as President and CEO, and Independent Directors Dr. Tamara Elias and Mr. James McElwee.

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

Poor Management Efficiency with a low ROE of 0%

The company has reported losses. Due to this company has reported negative ROE

Poor long term growth as Net Sales has grown by an annual rate of -3.33% and Operating profit at 2.53% over the last 5 years

Flat results in Sep 24

Risky - Not traded in last 10 days

Mojo Parameters

Stock DNA

Industry

Medical Specialties

Market cap

USD 2 Million (Micro Cap)

P/E

NA (Loss Making)

Industry P/E

Dividend Yield

0.00%

Debt Equity

-0.13

Return on Equity

-480.23%

Price to Book

0.40

Revenue and Profits:

Net Sales:

2 Million

(Quarterly Results - Sep 2024)

Net Profit:

-4 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

-41.48%

6 Months

-55.28%

1 Year

-83.99%

2 Years

-63.82%

3 Years

-99.38%

4 Years

-99.91%

5 Years

-99.74%

Avinger, Inc. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

-3.33%

EBIT Growth (5y)

2.53%

EBIT to Interest (avg)

-11.31

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-0.14

Sales to Capital Employed (avg)

0.61

Tax Ratio

Dividend Payout Ratio

Pledged Shares

Institutional Holding

8.66%

ROCE (avg)

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

0.40

EV to EBIT

-0.06

EV to EBITDA

-0.07

EV to Capital Employed

0.31

EV to Sales

0.14

PEG Ratio

Dividend Yield

ROCE (Latest)

-522.08%

ROE (Latest)

-480.23%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Dow Theory

Mildly Bullish

Bearish

OBV

Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Sep 2024

Shareholding Compare (%holding)

Majority shareholders

Domestic Funds

Held in 2 Schemes (1.6%)

Foreign Institutions

Held by 3 Foreign Institutions (0.0%)

Strategic Entities with highest holding

Highest Public shareholder

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Sep'24 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Sep 2024 is -11.11% vs -5.26% in Jun 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Sep 2024 is 15.91% vs 20.00% in Jun 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Jun'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1.60",
          "val2": "1.80",
          "chgp": "-11.11%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-3.30",
          "val2": "-3.80",
          "chgp": "13.16%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.20",
          "chgp": "-100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-3.70",
          "val2": "-4.40",
          "chgp": "15.91%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-2,223.60%",
          "val2": "-2,234.40%",
          "chgp": "1.08%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'23",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2023 is -7.23% vs -17.82% in Dec 2022",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2023 is -3.98% vs -1.15% in Dec 2022",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'23",
        "Dec'22",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "7.70",
          "val2": "8.30",
          "chgp": "-7.23%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-15.20",
          "val2": "-14.70",
          "chgp": "-3.40%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "1.70",
          "val2": "1.70",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-18.30",
          "val2": "-17.60",
          "chgp": "-3.98%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-2,173.90%",
          "val2": "-1,928.80%",
          "chgp": "-24.51%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Sep'24 - QoQ

Sep'24

Jun'24

Change(%)

Net Sales

1.60

1.80

-11.11%

Operating Profit (PBDIT) excl Other Income

-3.30

-3.80

13.16%

Interest

0.00

0.20

-100.00%

Exceptional Items

0.00

Consolidate Net Profit

-3.70

-4.40

15.91%

Operating Profit Margin (Excl OI)

-2,223.60%

-2,234.40%

1.08%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Sep 2024 is -11.11% vs -5.26% in Jun 2024

Consolidated Net Profit

QoQ Growth in quarter ended Sep 2024 is 15.91% vs 20.00% in Jun 2024

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'23

Dec'23

Dec'22

Change(%)

Net Sales

7.70

8.30

-7.23%

Operating Profit (PBDIT) excl Other Income

-15.20

-14.70

-3.40%

Interest

1.70

Exceptional Items

0.00

Consolidate Net Profit

-18.30

-17.60

-3.98%

Operating Profit Margin (Excl OI)

-2,173.90%

-1,928.80%

-24.51%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2023 is -7.23% vs -17.82% in Dec 2022

Consolidated Net Profit

YoY Growth in year ended Dec 2023 is -3.98% vs -1.15% in Dec 2022

All Annual Results

Company CV

About Avinger, Inc.

Avinger, Inc.

Medical Specialties

Avinger, Inc., (Avinger) is a commercial-stage medical device company. The Company designs, manufactures and sells image-guided, catheter-based systems that are used by physicians to treat patients with the peripheral arterial disease (PAD). The Company manufactures and sells a suite of products in the United States and select international markets. Avinger’s products include its Lightbox imaging console, the Ocelot family of catheters, which are designed to allow physicians to penetrate a total blockage in an artery, known as a chronic total occlusion (CTO), and Pantheris, an image-guided atherectomy device which is designed to allow physicians to precisely remove arterial plaque in PAD patients. The lumivascular platform offers real-time visualization of the inside of the artery during PAD treatment. The lumivascular platform consists of a capital component Lightbox and a range of disposable catheter products, including Ocelot, Ocelot PIXL, Ocelot MVRX and Pantheris.

Company Coordinates

Company Details

400 Chesapeake Dr , REDWOOD CITY CA : 94063-4739

Tel: 1 650 36324001 214 5978200

http://avinger.com/

Registrar Details

Avinger, Inc.

1Day

52 Week

CASH

FII

DII

Promoter

How big is Avinger, Inc.?

Watch in Real-Time

What does Avinger, Inc. do?

Should I buy, sell or hold Avinger, Inc.?

Who are in the management team of Avinger, Inc.?

MarketsMojo — Loved in India, Now Global

Dashboard

Poor Management Efficiency with a low ROE of 0%

Poor long term growth as Net Sales has grown by an annual rate of -3.33% and Operating profit at 2.53% over the last 5 years

Flat results in Sep 24

Risky - Not traded in last 10 days

Mojo Parameters

Stock DNA

Total Returns (Price + Dividend)

Risk Adjusted Returns v/s

News

Announcements

Corporate Actions

Quality key factors

Valuation key factors

Technicals key factors

Shareholding Snapshot : Sep 2024

Shareholding Compare (%holding)

Quarterly Results Snapshot (Consolidated) - Sep'24 - QoQ

Annual Results Snapshot (Consolidated) - Dec'23

About Avinger, Inc.

Company Coordinates